Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer

被引:6
作者
Mevizou, Rudy [1 ]
Sirvent, Audrey [1 ]
Roche, Serge [1 ]
机构
[1] Univ Montpellier, Equipe Labellisee Ligue Canc, CNRS, CRBM, F-34000 Montpellier, France
关键词
cell signalling; tyrosine kinase; small adaptor proteins; colorectal cancer; targeted therapy; SRC FAMILY KINASES; COLON-CANCER; CELL-PROLIFERATION; C-SRC; MYELOPROLIFERATIVE NEOPLASM; ABERRANT METHYLATION; HEMATOPOIETIC STEM; NEGATIVE REGULATOR; TUMOR PROGRESSION; PROTEIN SLAP;
D O I
10.3390/cancers11050669
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tyrosine kinases (TKs) phosphorylate proteins on tyrosine residues as an intracellular signalling mechanism to coordinate intestinal epithelial cell communication and fate decision. Deregulation of their activity is ultimately connected with carcinogenesis. In colorectal cancer (CRC), it is still unclear how aberrant TK activities contribute to tumour formation because TK-encoding genes are not frequently mutated in this cancer. In vertebrates, several TKs are under the control of small adaptor proteins with potential important physiopathological roles. For instance, they can exert tumour suppressor functions in human cancer by targeting several components of the oncogenic TK signalling cascades. Here, we review how the Src-like adaptor protein (SLAP) and the suppressor of cytokine signalling (SOCS) adaptor proteins regulate the SRC and the Janus kinase (JAK) oncogenic pathways, respectively, and how their loss of function in the intestinal epithelium may influence tumour formation. We also discuss the potential therapeutic value of these adaptors in CRC.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Tyrosine kinase signalling in breast cancer - Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates
    Kairouz, R
    Daly, RJ
    BREAST CANCER RESEARCH, 2000, 2 (03) : 197 - 202
  • [2] Tyrosine kinase signalling in breast cancer: Modulation of tyrosine kinase signalling in human breast cancer through altered expression of signalling intermediates
    Rania Kairouz
    Roger J Daly
    Breast Cancer Research, 2
  • [3] Absence of tyrosine kinase mutations in Japanese colorectal cancer patients
    Shao, R-X
    Kato, N.
    Lin, L-J
    Muroyama, R.
    Moriyama, M.
    Ikenoue, T.
    Watabe, H.
    Otsuka, M.
    Guleng, B.
    Ohta, M.
    Tanaka, Y.
    Kondo, S.
    Dharel, N.
    Chang, J-H
    Yoshida, H.
    Kawabe, T.
    Omata, M.
    ONCOGENE, 2007, 26 (14) : 2133 - 2135
  • [4] Absence of tyrosine kinase mutations in Japanese colorectal cancer patients
    R-X Shao
    N Kato
    L-J Lin
    R Muroyama
    M Moriyama
    T Ikenoue
    H Watabe
    M Otsuka
    B Guleng
    M Ohta
    Y Tanaka
    S Kondo
    N Dharel
    J-H Chang
    H Yoshida
    T Kawabe
    M Omata
    Oncogene, 2007, 26 : 2133 - 2135
  • [5] Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer
    Iyer, Kirti K.
    van Erp, Nielka P.
    Tauriello, Daniele V. F.
    Verheul, Henk M. W.
    Poel, Dennis
    CANCER TREATMENT REVIEWS, 2022, 110
  • [6] The role of protein tyrosine phosphatases in colorectal cancer
    Hoekstra, Elmer
    Peppelenbosch, Maikel P.
    Fuhler, Gwenny M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (01): : 179 - 188
  • [7] Calcium signalling and control of cell proliferation by tyrosine kinase receptors (review)
    Munaron, L
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2002, 10 (06) : 671 - 676
  • [8] Bruton's tyrosine kinase (Btk) - the critical tyrosine kinase in LPS signalling?
    Jefferies, CA
    O'Neill, LAJ
    IMMUNOLOGY LETTERS, 2004, 92 (1-2) : 15 - 22
  • [9] Therapeutic Potential of Protein Tyrosine Kinase 6 in Colorectal Cancer
    Jerin, Samanta
    Harvey, Amanda J.
    Lewis, Annabelle
    CANCERS, 2023, 15 (14)
  • [10] The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
    Ruehlmann, Felix
    Nietert, Manuel
    Sprenger, Thilo
    Wolff, Hendrik A.
    Homayounfar, Kia
    Middel, Peter
    Bohnenberger, Hanibal
    Beissbarth, Tim
    Ghadimi, B. Michael
    Liersch, Torsten
    Conradi, Lena-Christin
    JOURNAL OF CANCER, 2017, 8 (07): : 1229 - 1237